Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Furosemide Injection
Status: Currently in Shortage
»Date first posted:
04/07/2020
»Therapeutic Categories: Cardiovascular
Accord Healthcare Inc. (Reverified 03/05/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 16729-500-08) | Unavailable | Inventory on hold pending further assessment. | Requirements related to complying with good manufacturing practices |
Injection, 10 mg/1 mL (NDC 16729-501-43) | Unavailable | Inventory on hold pending further assessment. | Requirements related to complying with good manufacturing practices |
Injection, 10 mg/1 mL (NDC 16729-502-43) | Unavailable | Inventory on hold pending further assessment. | Requirements related to complying with good manufacturing practices |
Avet Pharmaceuticals, Inc. (Reverified 03/15/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 23155-473-41) | Available | ||
Injection, 10 mg/1 mL (NDC 23155-473-42) | Available | ||
Injection, 10 mg/1 mL (NDC 23155-473-44) | Available |
Baxter Healthcare (Reverified 03/18/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25) | Available | ||
Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25) | Available | ||
Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25) | Available |
Eugia US LLC (Reverified 03/21/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 20 mg/2 mL (NDC 55150-322-25) | Currently on backorder - next shipment TBD | Intermittent availability expected | Demand increase for the drug |
Injection, 40 mg/4 mL (NDC 55150-323-25) | Available | Check wholesalers for inventory | |
Injection, 100 mg/10 mL (NDC 55150-324-25) | Available | Check wholesalers for inventory |
Fresenius Kabi USA, LLC (Reverified 03/20/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 63323-280-02) | Available | Check wholesalers for inventory. | |
Injection, 10 mg/1 mL (NDC 63323-280-04) | Available | Check wholesalers for inventory. | |
Injection, 10 mg/1 mL (NDC 63323-280-10) | Unavailable | Backordered. Next release April 2024; Check wholesalers for inventory. | Demand increase for the drug |
Gland Pharma Limited (Revised 03/15/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02) | Available | ||
Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04) | Available | ||
Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10) | Available |
Hospira, Inc., a Pfizer Company (Revised 02/27/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 0409-6102-02) | Available | ||
Injection, 10 mg/1 mL (NDC 0409-6102-04) | Available | ||
Furosemide, Injection, 10 mg/1 mL (NDC 0409-6102-10) | Available | ||
Furosemide, Injection, 10 mg/1 mL (NDC 0409-6102-25) | Available | ||
Injection, 10 mg/1 mL (NDC 0409-6102-26) | Available | ||
Injection, 10 mg/1 mL (NDC 0409-6102-27) | Available |
Meitheal Pharmaceuticals, Inc. (Reverified 03/20/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/mL, 2 mL (NDC 71288-205-03) | Available | ||
Injection, 10 mg/1 mL (NDC 71288-203-05) | Available | ||
Injection, 10 mg/1 mL (NDC 71288-203-11) | Available |
Sagent Pharmaceuticals (Revised 03/06/2024)
Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
---|---|---|---|
Injection, 10 mg/1 mL (NDC 70860-302-02) | Available | Use Sagent NDC 25021-311-02 | Demand increase for the drug |
Injection, 10 mg/1 mL (NDC 70860-302-04) | Available | ||
Injection, 10 mg/1 mL (NDC 70860-302-10) | Available | ||
Injection, 10 mg/1 mL (NDC 25021-311-02) | Available | ||
Injection, 10 mg/1 mL (NDC 25021-311-04) | Available | ||
Injection, 10 mg/1 mL (NDC 25021-311-10) | Available |